- Report
- December 2025
- 71 Pages
Asia Pacific
From €2875EUR$3,250USD£2,494GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5264EUR$5,950USD£4,567GBP
- Report
- September 2025
- 120 Pages
Middle East
From €5264EUR$5,950USD£4,567GBP
- Report
- September 2025
- 120 Pages
United States
From €5264EUR$5,950USD£4,567GBP
- Report
- September 2025
- 150 Pages
United States
From €5264EUR$5,950USD£4,567GBP
- Report
- September 2025
- 85 Pages
United States
From €3097EUR$3,500USD£2,686GBP
- Report
- June 2025
- 83 Pages
United States
From €3097EUR$3,500USD£2,686GBP
- Report
- May 2025
- 105 Pages
Europe
From €4202EUR$4,750USD£3,646GBP
- Report
- November 2025
- 92 Pages
Europe
From €3495EUR$3,950USD£3,032GBP
- Report
- October 2025
- 84 Pages
United States
From €4291EUR$4,850USD£3,722GBP
- Report
- October 2025
- 93 Pages
Oman, Middle East
From €4291EUR$4,850USD£3,722GBP
- Report
- October 2025
- 90 Pages
Asia Pacific
From €4291EUR$4,850USD£3,722GBP
From €4291EUR$4,850USD£3,722GBP
From €4291EUR$4,850USD£3,722GBP
- Report
- October 2025
- 88 Pages
Middle East
From €4291EUR$4,850USD£3,722GBP
- Report
- October 2025
- 100 Pages
Asia Pacific
From €4291EUR$4,850USD£3,722GBP
- Report
- September 2025
- 99 Pages
United States
From €4291EUR$4,850USD£3,722GBP
- Report
- March 2025
- 355 Pages
Global
From €5190EUR$6,071USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5190EUR$6,071USD£4,350GBP
- Report
- August 2023
- 334 Pages
Global
From €4713EUR$5,513USD£3,950GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more